Published in PLOS One on 2026-04-15, this study is presented as an attributed evidence briefing. The excerpts below are the original researchers’ words, reproduced under their Creative Commons Attribution licence. Health Signal has selected the abstract and, where needed, opening background paragraphs; the complete methods, results, limitations and references remain in the linked paper.
Original authors: Cynthia Mmalebna Amisigo, Gloria Amegatcher, Jack D. Sunter, Theresa Manful Gwira
Source: PLOS One • DOI 10.1371/journal.pone.0347099
Read the complete primary study ↗ · Creative Commons Attribution licence
From the researchers
Abstract
African trypanosomiasis is a deadly disease that affects humans and animals, with treatment hindered by drug toxicity and resistance, highlighting the need for alternative therapies. Alkyl gallates, which are plant-derived phenolipids used in the food, cosmetics, and pharmaceutical industries, have been shown to have potent anti-microbial activity; however, their mechanism of action is still unclear. This study investigated the effects of selected alkyl gallates on Trypanosoma brucei. The in vitro anti-trypanosomal and cytotoxicity of the alkyl gallates were determined using the alamarBlue assay. The effects of the alkyl gallates on lipid droplet dynamics were studied using BODIPY493/503 dye and an endogenously tagged lipid droplet kinase cell line which served as a protein marker of lipid droplets. In vitro treatment with octyl and lauryl gallates resulted in rapid cell death with low IC50 of 0.7 µM and 0.04 µM respectively. Octyl gallate treatment significantly reduced lipid droplet number within 30 minutes and by 2 hours most cells lacked lipid droplets; however, lipid droplets rebounded once the drug pressure was removed. These results show that alkyl gallates rapidly disrupt lipid droplet homeostasis in Trypanosoma brucei. Thus, these gallates could serve as a useful cell biology tool to dissect lipid droplet biogenesis and function in trypanosomes.
Introduction
Trypanosoma brucei (T. brucei) is a unicellular flagellate protozoan parasite that causes African trypanosomiasis, an infectious disease affecting humans, wildlife and livestock. Over 55 million individuals are at risk from the disease, and annual losses in livestock production are estimated at $4.5 billion [1,2]. The life cycle of T. brucei alternates between the insect vector (tsetse fly) and the mammalian host in which the parasites are found in the extravascular and intravascular compartments including the adipose and the skin [3–5]. Throughout their life cycle, trypanosomes are exposed to different environmental conditions within the mammalian host and the vector such as changes in pH, nutrients and energy sources, and one of the ways they respond to these environmental changes is by adjusting their metabolism [6,7].
Lipid metabolism is an important process in most living organisms and is based on the environment they find themselves [6,8]. For example, trypanosomes found in adipose tissue alter the gene expression of lipid metabolism-related genes to use lipids/fatty acids as a carbon source [5]. Lipid droplets are one of the important components of the lipid metabolism process. They are lipid/fat storing organelles found in the cytosol of all eukaryotes and some prokaryotic cells [9,10]. Apart from serving as storage compartments, lipid droplets are also involved in energy metabolism, lipid trafficking, protection against oxidative stress, and lipotoxicity [11]. Lipid droplets are made up of a monolayer of phospholipid and cholesterol surrounding a hydrophobic core of neutral lipids like triacylglycerides and sterol esters [12]. Studies have shown that the synthesis and/or maintenance of the lipid droplet in T. brucei and Leishmania infantum requires a protein called the lipid droplet kinase, which localizes to the periphery of the lipid droplet [13,14]. To date, evidence suggests that lipid droplets are essential for the regulation of lipid metabolism in the parasite [15]; however, the tools are lacking to unravel the functional detail of these organelles.
Reading this evidence
Use the full paper to check the study design, participant selection, comparator and outcome definitions before drawing a practical conclusion. An association does not by itself show cause and effect. A reported performance measure needs its denominator and uncertainty. A finding from a particular facility, sample or time period should retain that scope when it is discussed elsewhere.
This briefing makes the source accessible within the wider research & evidence desk. It does not assess an individual patient or certify a product. When considering relevance to another health system, examine the original authors’ account of context and limitations, then seek local implementation evidence. The related reporting below provides other studies to read alongside this one; it is a topic connection, rather than a claim that their results are directly comparable.
© 2026 Cynthia Mmalebna Amisigo, Gloria Amegatcher, Jack D. Sunter, Theresa Manful Gwira. Excerpts reproduced under CC BY. Selection, formatting and contextual notes by Health Signal. The researchers are the authors of the source study, not members of Health Signal’s staff.
Explore connected evidence
- Evidence brief: Prevalence, treatment rates and control of dyslipidemia among diabetes patients in northern Nigeria: A cross-sectional, multicenter study
- Evidence brief: Synergistic antifungal activity of antiretrovirals with amphotericin B against Aspergillus species
- Evidence brief: In vitro and in vivo antibacterial activities and phytochemical screening of 80% methanol extract from Ehretia cymosa leaves

